person · Reporting owner
Robinson William G Jr
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMERICAN PUBLIC EDUCATION INCAPEI · Entity 5082 | Director | May 17, 2024 | May 20, 2024 |
| CLOVER HEALTH INVESTMENTS, CORP. /DECLOV · Entity 4419 | Director | January 06, 2026 | January 08, 2026 |
| Sabre CorpSABR · Entity 5098 | Executive Vice President | March 28, 2017 | March 29, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMERICAN PUBLIC EDUCATION INC
Report date May 17, 2024 · Filed May 20, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $.01SEC Table I · non-derivative | Direct | 43,935 |
Reported balance
After 2024-05-17 transaction · row 1
1 source rowRow 1 · 2024-05-17 · Grant · Acquired 4,350 · Balance 43,935 F1: Pursuant to the non-employee director compensation policy of American Public Education, Inc. (the "Company"), each non-employee director receives an annual award of restricted common stock of the Company having a value of $80,000 on the grant date. The shares vest on the earlier of the one year anniversary of the grant date and immediately prior to the Company's 2025 Annual Meeting of Stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the non-employee director compensation policy of American Public Education, Inc. (the "Company"), each non-employee director receives an annual award of restricted common stock of the Company having a value of $80,000 on the grant date. The shares vest on the earlier of the one year anniversary of the grant date and immediately prior to the Company's 2025 Annual Meeting of Stockholders.
CLOVER HEALTH INVESTMENTS, CORP. /DE
Report date January 06, 2026 · Filed January 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 597,987 |
Reported balance
After 2026-01-06 transaction · row 1
1 source rowRow 1 · 2026-01-06 · Grant · Acquired 79,365 · Balance 597,987 F1: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2026, subject to the Reporting Person's continued service as a director through such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2026, subject to the Reporting Person's continued service as a director through such vesting date.
Sabre Corp
Report date March 28, 2017 · Filed March 29, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 113,531 |
Reported balance
After 2017-03-28 transaction · row 1
1 source rowRow 1 · 2017-03-28 · Sale · Disposed 20,837 · Balance 113,531 F1: This transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on August 3, 2016. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.86 to $21.28, inclusive. The reporting person undertakes to provide to Sabre Corporation, any security holder of Sabre Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on August 3, 2016.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.86 to $21.28, inclusive. The reporting person undertakes to provide to Sabre Corporation, any security holder of Sabre Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 06, 2026 Filed Jan 8, 2026 16:05 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 79,365 | $0.00 | $0.00 |
DisclosureSEC source: 0001801170-26-000007 · wk-form4_1767906326.xml · nonDerivative · entry 1 Robinson William G Jr · CIK 0001604046 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 597,987 F1 · shares: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2026, subject to the Reporting Person's continued service as a director through such vesting date. Read SEC document |
| January 06, 2025 Filed Jan 8, 2025 16:44 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 60,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001801170-25-000018 · wk-form4_1736372634.xml · nonDerivative · entry 1 Robinson William G Jr · CIK 0001604046 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 518,622 F1 · shares: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2025, subject to the Reporting Person's continued service as a director through such vesting date. Read SEC document |
| May 17, 2024 Filed May 20, 2024 20:07 UTC | AMERICAN PUBLIC EDUCATION INC APEI · Entity 5082 | GrantCommon Stock, par value $.01 | 4,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-010791 · form4.xml · nonDerivative · entry 1 Robinson William G Jr · CIK 0001604046 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,935 F1 · shares: Pursuant to the non-employee director compensation policy of American Public Education, Inc. (the "Company"), each non-employee director receives an annual award of restricted common stock of the Company having a value of $80,000 on the grant date. The shares vest on the earlier of the one year anniversary of the grant date and immediately prior to the Company's 2025 Annual Meeting of Stockholders. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 16:20 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 206,185 | $0.97 | $199,999.45 |
DisclosureSEC source: 0001801170-24-000025 · wk-form4_1704489606.xml · nonDerivative · entry 1 Robinson William G Jr · CIK 0001604046 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 457,647 F1 · shares: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 3, 2024, subject to the Reporting Person's continued service as a director through such vesting date. Read SEC document |
| May 19, 2023 Filed May 22, 2023 20:05 UTC | AMERICAN PUBLIC EDUCATION INC APEI · Entity 5082 | GrantCommon Stock, par value $.01 | 12,738 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-011908 · form4.xml · nonDerivative · entry 1 Robinson William G Jr · CIK 0001604046 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,585 F1 · shares: Pursuant to the non-employee director compensation policy of American Public Education, Inc. (the "Company"), each non-employee director receives an annual award of restricted common stock of the Company having a value of $80,000 on the grant date. The shares vest on the earlier of the one year anniversary of the grant date and immediately prior to the Company's 2024 Annual Meeting of Stockholders. Read SEC document |
| March 21, 2023 Filed Mar 22, 2023 20:05 UTC | AMERICAN PUBLIC EDUCATION INC APEI · Entity 5082 | PurchaseCommon Stock, par value $.01 | 6,250 | $4.06 | $25,375.00 |
DisclosureSEC source: 0001062993-23-007484 · form4.xml · nonDerivative · entry 1 Robinson William G Jr · CIK 0001604046 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,847 Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 16:37 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 176,991 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-000470 · wf-form4_167295461765065.xml · nonDerivative · entry 1 Robinson William G Jr · CIK 0001604046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,462 F1 · shares: Represents shares of Class A common stock of Clover Health Investments, Corp. (the "Company") underlying a time-based restricted stock unit award ("RSUs"). The RSUs will vest in full on the first anniversary of January 3, 2023, subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such vesting date. Read SEC document |
| September 22, 2022 Filed Sep 26, 2022 18:02 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Exercise / conversionRestricted Stock Unit · Derivative | 27,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-025509 · wf-form4_166422975290506.xml · derivative · entry 3 Robinson William G Jr · CIK 0001604046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 27,100 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The remaining number of the shares subject to the RSU award vested on the date of the 2022 Annual Meeting. F3 · derivative.expiration_date: The remaining number of the shares subject to the RSU award vested on the date of the 2022 Annual Meeting. Read SEC document |
| September 22, 2022 Filed Sep 26, 2022 18:02 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 20,271 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-025509 · wf-form4_166422975290506.xml · nonDerivative · entry 2 Robinson William G Jr · CIK 0001604046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,471 F2 · shares: Represents shares of Class A common stock underlying a time-based RSUs. One hundred percent of the RSUs will vest on the first anniversary of the Date of Grant, subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such date. Read SEC document |
| September 22, 2022 Filed Sep 26, 2022 18:02 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Exercise / conversionClass A Common Stock | 27,100 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-22-025509 · wf-form4_166422975290506.xml · nonDerivative · entry 1 Robinson William G Jr · CIK 0001604046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Read SEC document |
| May 20, 2022 Filed May 24, 2022 23:31 UTC | AMERICAN PUBLIC EDUCATION INC APEI · Entity 5082 | GrantCommon Stock, par value $.01 | 5,956 | $13.43 | $79,989.08 |
DisclosureSEC source: 0001062993-22-013421 · form4.xml · nonDerivative · entry 1 Robinson William G Jr · CIK 0001604046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,597 F1 · shares: Under the director compensation policy for non-employee directors of American Public Education, Inc. (the "Company"), the Company's Management Development & Compensation Committee annually grants each non-employee director an award of restricted common stock of the Company having a value of $80,000 on the date of grant. The shares vest on the earlier of the one year anniversary of the date of grant and immediately prior to the Company's 2023 Annual Meeting of Stockholders. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 21:23 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Exercise / conversionRestricted Stock Unit · Derivative | 27,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-000725 · wf-form4_164195418269205.xml · derivative · entry 2 Robinson William G Jr · CIK 0001604046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,100 Underlying: Class A Common Stock · 27,100 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. F2 · derivative.exercise_date: The RSUs vested as to 50% of the shares subject to the award on January 7, 2022, and will vest as to the remaining shares subject to the award on the date of the 2022 Annual Meeting, subject to the Reporting Person's continued service as a member of the Board through such vesting date. F2 · derivative.expiration_date: The RSUs vested as to 50% of the shares subject to the award on January 7, 2022, and will vest as to the remaining shares subject to the award on the date of the 2022 Annual Meeting, subject to the Reporting Person's continued service as a member of the Board through such vesting date. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 21:23 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Exercise / conversionClass A Common Stock | 27,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-000725 · wf-form4_164195418269205.xml · nonDerivative · entry 1 Robinson William G Jr · CIK 0001604046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2021 Filed May 25, 2021 21:37 UTC | AMERICAN PUBLIC EDUCATION INC APEI · Entity 5082 | GrantCommon Stock, par value $.01 | 2,845 | $28.11 | $79,972.95 |
DisclosureSEC source: 0001123292-21-000876 · edgar.xml · nonDerivative · entry 1 Robinson William G Jr · CIK 0001604046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,641 F1 · shares: Under the director compensation policy for non-employee directors of American Public Education, Inc. (the "Company"), the Company's Management Development & Compensation Committee annually grants each non-employee director an award of restricted common stock of the Company having a value of $80,000 on the date of grant. The shares vest on the earlier of the one year anniversary of the date of grant and immediately prior to the 2022 annual meeting of stockholders. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 18:07 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantRestricted Stock Unit · Derivative | 54,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-024771 · doc4.xml · derivative · entry 1 Robinson William G Jr · CIK 0001604046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,200 Underlying: Class A Common Stock · 54,200 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. F2 · derivative.exercise_date: The RSUs will vest as to 50% of the shares subject to the award on the first anniversary of January 7, 2021, and will vest as to the remaining shares subject to the award on the date of the 2022 Annual Meeting, subject to the Reporting Person's continued service as a member of the Board through each such vesting date. F2 · derivative.expiration_date: The RSUs will vest as to 50% of the shares subject to the award on the first anniversary of January 7, 2021, and will vest as to the remaining shares subject to the award on the date of the 2022 Annual Meeting, subject to the Reporting Person's continued service as a member of the Board through each such vesting date. Read SEC document |
| May 15, 2020 Filed May 19, 2020 20:31 UTC | AMERICAN PUBLIC EDUCATION INC APEI · Entity 5082 | GrantCommon Stock, par value $.01 | 2,520 | $31.74 | $79,984.80 |
DisclosureSEC source: 0001123292-20-000739 · edgar.xml · nonDerivative · entry 1 Robinson William G Jr · CIK 0001604046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,796 F1 · shares: Under the director compensation policy for non-employee directors of American Public Education, Inc. (the "Company"), the Company's Management Development & Compensation Committee annually grants each non-employee director an award of restricted common stock of the Company having a value of $80,000 on the date of grant. The shares vest on the earlier of the one year anniversary of the date of grant and immediately prior to the 2021 annual meeting of stockholders. Read SEC document |
| May 10, 2019 Filed May 14, 2019 20:16 UTC | AMERICAN PUBLIC EDUCATION INC APEI · Entity 5082 | GrantCommon Stock, par value $.01 | 2,468 | $30.38 | $74,977.84 |
DisclosureSEC source: 0001123292-19-000767 · edgar.xml · nonDerivative · entry 1 Robinson William G Jr · CIK 0001604046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,276 F1 · shares: Under the director compensation policy for non-employee directors of American Public Education, Inc. (the "Company"), the Company's compensation committee annually grants each non-employee director an award of restricted common stock of the Company having a value of $75,000 on the date of grant. The shares vest on the earlier of the one year anniversary of the date of grant and immediately prior to the 2020 annual meeting of stockholders. Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:19 UTC | AMERICAN PUBLIC EDUCATION INC APEI · Entity 5082 | GrantCommon Stock, par value $.01 | 1,720 | $43.60 | $74,992.00 |
DisclosureSEC source: 0001123292-18-000792 · edgar.xml · nonDerivative · entry 1 Robinson William G Jr · CIK 0001604046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,808 F1 · shares: Under the director compensation policy for non-employee directors of American Public Education, Inc. (the "Company"), the Company's compensation committee annually grants each non-employee director an award of restricted common stock of the Company having a value of $75,000 on the date of grant. The shares vest on the earlier of the one year anniversary of the date of grant and immediately prior to the 2019 annual meeting of stockholders. Read SEC document |
| May 15, 2017 Filed May 17, 2017 20:20 UTC | AMERICAN PUBLIC EDUCATION INC APEI · Entity 5082 | GrantCommon Stock, par value $.01 | 3,105 | $24.15 | $74,985.75 |
DisclosureSEC source: 0001123292-17-000965 · edgar.xml · nonDerivative · entry 1 Robinson William G Jr · CIK 0001604046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,088 F1 · shares: Under the director compensation policy for non-employee directors of American Public Education, Inc. (the "Company"), the Company's compensation committee annually grants each non-employee director an award of restricted common stock of the Company having a value of $75,000 on the date of grant. The shares vest on the earlier of the one year anniversary of the date of grant and immediately prior to the 2018 annual meeting of stockholders. Read SEC document |
| March 28, 2017 Filed Mar 29, 2017 20:04 UTC | Sabre Corp SABR · Entity 5098 | SaleCommon Stock | 20,837 | $21.03 | $438,245.87 |
DisclosureSEC source: 0001597033-17-000077 · wf-form4_149081784935095.xml · nonDerivative · entry 1 Robinson William G Jr · CIK 0001604046 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,531 F1 · kind: This transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on August 3, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.86 to $21.28, inclusive. The reporting person undertakes to provide to Sabre Corporation, any security holder of Sabre Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 22:29 UTC | Sabre Corp SABR · Entity 5098 | GrantOptions to Purchase Common Stock · Derivative | 69,659 | $0.00 Strike: $22.01 | $0.00 |
DisclosureSEC source: 0001597033-17-000067 · wf-form4_148978973492980.xml · derivative · entry 3 Robinson William G Jr · CIK 0001604046 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,659 Underlying: Common Stock · 69,659 shares Expires 2027-03-15 F3 · derivative.exercise_date: The options vest and become exercisable as to 25% of the shares of Common Stock of the Issuer subject to each such option on the first anniversary of the date of grant and as to 6.25% of such shares at the end of each successive three-month period thereafter, subject to the reporting person's continued employment with the Issuer through each vesting date. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 22:29 UTC | Sabre Corp SABR · Entity 5098 | Tax withholdingCommon Stock | 21,292 | $22.04 | $469,275.68 |
DisclosureSEC source: 0001597033-17-000067 · wf-form4_148978973492980.xml · nonDerivative · entry 2 Robinson William G Jr · CIK 0001604046 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,368 F2 · kind: This transaction represents the automatic surrender of shares to the issuer upon vesting of performance-based restricted shares units to satisfy the reporting person's tax withholding obligations. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 22:29 UTC | Sabre Corp SABR · Entity 5098 | GrantCommon Stock | 62,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001597033-17-000067 · wf-form4_148978973492980.xml · nonDerivative · entry 1 Robinson William G Jr · CIK 0001604046 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,660 F1 · shares: Represents performance-based restricted share units that have vested and are paid out in shares of common stock. 24,695 shares are from a grant dated 12/16/2013, 11,241 shares are from a grant dated 4/17/2014, 13,627 shares are from a grant dated 3/13/2015, and 13,404 shares are from a grant dated 3/15/2016. Read SEC document |
| December 16, 2016 Filed Dec 19, 2016 21:26 UTC | Sabre Corp SABR · Entity 5098 | Exercise / conversionOptions to Purchase Common Stock · Derivative | 18,521 | $0.00 Strike: $14.01 | $0.00 |
DisclosureSEC source: 0001597033-16-000327 · wf-form4_148218278751177.xml · derivative · entry 6 Robinson William G Jr · CIK 0001604046 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,085 Underlying: Common Stock · 18,521 shares Expires 2023-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on August 3, 2016. F5 · derivative.exercise_date: The options vest and become exercisable as to 25% of the shares of Common Stock subject to each such option on the first anniversary of the date of grant and as to 6.25% of such shares at the end of each successive three-month period thereafter, subject to the Reporting Person's continued employment through each vesting date. Read SEC document |
| December 16, 2016 Filed Dec 19, 2016 21:26 UTC | Sabre Corp SABR · Entity 5098 | Exercise / conversionOptions to Purchase Common Stock · Derivative | 3,235 | $0.00 Strike: $16.68 | $0.00 |
DisclosureSEC source: 0001597033-16-000327 · wf-form4_148218278751177.xml · derivative · entry 5 Robinson William G Jr · CIK 0001604046 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,175 Underlying: Common Stock · 3,235 shares Expires 2024-04-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on August 3, 2016. F4 · derivative.exercise_date: The options vest and become exercisable as to 25% of the shares of common stock, par value $0.01 per share (the "Common Stock") subject to each such option on March 15, 2015 and as to 6.25% of such shares of Common Stock at the end of each successive three-month period thereafter, subject to the Reporting Person's continued employment through each vesting date. Read SEC document |
| December 16, 2016 Filed Dec 19, 2016 21:26 UTC | Sabre Corp SABR · Entity 5098 | SaleCommon Stock | 21,756 | $25.32 | $550,757.49 |
DisclosureSEC source: 0001597033-16-000327 · wf-form4_148218278751177.xml · nonDerivative · entry 4 Robinson William G Jr · CIK 0001604046 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,693 F2 · kind: This transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on August 3, 2016. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.23 to $25.44, inclusive. The reporting person undertakes to provide to Sabre Corporation, any security holder of Sabre Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| December 16, 2016 Filed Dec 19, 2016 21:26 UTC | Sabre Corp SABR · Entity 5098 | Exercise / conversionCommon Stock | 18,521 | $14.01 | $259,479.21 |
DisclosureSEC source: 0001597033-16-000327 · wf-form4_148218278751177.xml · nonDerivative · entry 3 Robinson William G Jr · CIK 0001604046 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,449 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on August 3, 2016. Read SEC document |
| December 16, 2016 Filed Dec 19, 2016 21:26 UTC | Sabre Corp SABR · Entity 5098 | Exercise / conversionCommon Stock | 3,235 | $16.68 | $53,959.80 |
DisclosureSEC source: 0001597033-16-000327 · wf-form4_148218278751177.xml · nonDerivative · entry 2 Robinson William G Jr · CIK 0001604046 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,928 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on August 3, 2016. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 21:26 UTC | Sabre Corp SABR · Entity 5098 | GrantCommon Stock | 44,239 | $0.00 | $0.00 |
DisclosureSEC source: 0001597033-16-000327 · wf-form4_148218278751177.xml · nonDerivative · entry 1 Robinson William G Jr · CIK 0001604046 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,693 F1 · shares: The Reporting Person received a grant of restricted stock units on the transaction date. The restricted stock unit award vests as to 100% of the shares of common stock subject to the award at the end ofthe three-year period following the grant date, subject to the reporting person's continued employment with the Issuer through the vesting date. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 20:41 UTC | Sabre Corp SABR · Entity 5098 | Exercise / conversionOptions to Purchase Common Stock · Derivative | 20,439 | $0.00 Strike: $22.15 | $0.00 |
DisclosureSEC source: 0001597033-16-000275 · wf-form4_147570005126714.xml · derivative · entry 3 Robinson William G Jr · CIK 0001604046 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,067 Underlying: Common Stock · 20,439 shares Expires 2025-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on August 3, 2016. F3 · derivative.exercise_date: The options vest and become exercisable as to 25% of the shares of Common Stock of the Issuer subject to each such option on the first anniversary of the date of grant and as to 6.25% of such shares at the end of each successive three-month period thereafter, subject to the reporting person's continued employment with the Issuer through each vesting date. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 20:41 UTC | Sabre Corp SABR · Entity 5098 | SaleCommon Stock | 20,439 | $28.01 | $572,510.70 |
DisclosureSEC source: 0001597033-16-000275 · wf-form4_147570005126714.xml · nonDerivative · entry 2 Robinson William G Jr · CIK 0001604046 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,454 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on August 3, 2016. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.09, inclusive. The reporting person undertakes to provide to Sabre Corporation, any security holder of Sabre Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 20:41 UTC | Sabre Corp SABR · Entity 5098 | Exercise / conversionCommon Stock | 20,439 | $22.15 | $452,723.85 |
DisclosureSEC source: 0001597033-16-000275 · wf-form4_147570005126714.xml · nonDerivative · entry 1 Robinson William G Jr · CIK 0001604046 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,893 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on August 3, 2016. Read SEC document |
| September 19, 2016 Filed Sep 20, 2016 20:49 UTC | Sabre Corp SABR · Entity 5098 | Exercise / conversionOptions to Purchase Common Stock · Derivative | 12,940 | $0.00 Strike: $16.68 | $0.00 |
DisclosureSEC source: 0001597033-16-000265 · wf-form4_147440458005021.xml · derivative · entry 5 Robinson William G Jr · CIK 0001604046 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,410 Underlying: Common Stock · 12,940 shares Expires 2024-04-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on August 3, 2016. F3 · derivative.exercise_date: The options vest and become exercisable as to 25% of the shares of common stock, par value $0.01 per share (the "Common Stock") of Sabre Corporation subject to each such option on the first anniversary of the date of grant and as to 6.25% of such shares at the end of each successive three-month period thereafter, subject to Mr. Robinson's continued employment through each vesting date. Read SEC document |
| September 19, 2016 Filed Sep 20, 2016 20:49 UTC | Sabre Corp SABR · Entity 5098 | Exercise / conversionOptions to Purchase Common Stock · Derivative | 74,084 | $0.00 Strike: $14.01 | $0.00 |
DisclosureSEC source: 0001597033-16-000265 · wf-form4_147440458005021.xml · derivative · entry 4 Robinson William G Jr · CIK 0001604046 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,606 Underlying: Common Stock · 74,084 shares Expires 2023-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on August 3, 2016. F3 · derivative.exercise_date: The options vest and become exercisable as to 25% of the shares of common stock, par value $0.01 per share (the "Common Stock") of Sabre Corporation subject to each such option on the first anniversary of the date of grant and as to 6.25% of such shares at the end of each successive three-month period thereafter, subject to Mr. Robinson's continued employment through each vesting date. Read SEC document |
| September 19, 2016 Filed Sep 20, 2016 20:49 UTC | Sabre Corp SABR · Entity 5098 | SaleCommon Stock | 114,213 | $26.96 | $3,079,216.74 |
DisclosureSEC source: 0001597033-16-000265 · wf-form4_147440458005021.xml · nonDerivative · entry 3 Robinson William G Jr · CIK 0001604046 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,454 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on August 3, 2016. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.85 to $27.12, inclusive. The reporting person undertakes to provide to Sabre Corporation, any security holder of Sabre Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| September 19, 2016 Filed Sep 20, 2016 20:49 UTC | Sabre Corp SABR · Entity 5098 | Exercise / conversionCommon Stock | 12,940 | $16.68 | $215,839.20 |
DisclosureSEC source: 0001597033-16-000265 · wf-form4_147440458005021.xml · nonDerivative · entry 2 Robinson William G Jr · CIK 0001604046 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on August 3, 2016. Read SEC document |
| September 19, 2016 Filed Sep 20, 2016 20:49 UTC | Sabre Corp SABR · Entity 5098 | Exercise / conversionCommon Stock | 74,084 | $14.01 | $1,037,916.84 |
DisclosureSEC source: 0001597033-16-000265 · wf-form4_147440458005021.xml · nonDerivative · entry 1 Robinson William G Jr · CIK 0001604046 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,727 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on August 3, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.